期刊文献+

B型利钠肽联合临床指标对急性冠脉综合征患者预后的意义

Prognostic Significance of B-type Natriuretic Peptide Combined with Clinical Indicators in Patients with Acute Coronary Syndrome
下载PDF
导出
摘要 目的探讨B型利钠肽(BNP)结合临床指标在急性冠脉综合征(ACS)患者预后评估中的诊断作用。方法选取2018年1月至2019年1月重庆市丰都县人民医院心内科确诊的97例急性冠脉综合征(ACS)患者为研究对象,入院时所有患者均检测血浆BNP水平、左心室射血分数(LVEF),并与40例健康人(对照组)作对照,随访观察1年,记录心脏不良事件(MACE)的发生情况。利用多因素COX风险比例模型分析影响ACS患者预后的独立危险因素。绘制受试者工作特征(receiver operator characteristic,ROC)曲线分析BNP及LVEF等指标,对ACS患者出院后1年的MACE事件进行预测。结果ACS患者的BNP水平明显高于对照组(t=9.057,P<0.05)。与未发生MACE事件的患者相比,发生事件的患者BNP水平显著升高(t=2.953,P<0.05)。多因素COX模型显示,矫正了LVEF和年龄后,BNP>500 pg/mL仍然是预期其1年MACE事件的独立危险因素。ROC曲线显示,BNP对于1年MACE事件的预测能力较好(AUC:0.72),但结合LVEF、年龄后,预测能力显著升高(AUC:0.79),敏感性(73.2%)及特异性(80.0%)也有所提高。结论ACS患者住院期间所测的BNP水平结合LVEF及年龄可以提高其对ACS患者出院后1年MACE时间的预测价值。有效的监测ACS患者血浆BNP水平,对预测病情和评估预后具有重要的临床意义。 Objective To investigate the diagnostic value of B-type natriuretic peptide(BNP)combined with clinical indicators in prognosis evaluation of patients with acute coronary syndrome(ACS).Methods From January 2018 to January 2019,97 patients with ACS diagnosed in the Department of Cardiology of Fengdu People's Hospital of Chongqing were selected as the research objects.Plasma BNP levels and left ventricular ejection fraction(LVEF)were measured in all patients at admission,and compared with 40 healthy people(control group).The patients were followed up for one year,and the incidence of adverse cardiac events(MACE)was recorded.Multivariate COX risk ratio model was used to analyze the independent risk factors affecting the prognosis of ACS patients.Receiver operator characteristic(ROC)curve was drawn to analyze the prediction of mace events by BNP and LVEF in ACS patients one year after discharge.Results BNP level in ACS patients was significantly higher than that in control group(t=9.057,P<0.05).Compared with patients without MACE,BNP levels in patients with MACE events were significantly higher(t=2.953,P<0.05).After adjusting for LVEF and age,BNP>500 pg/mL was still an independent risk factor for MACE events.ROC curve showed that BNP had better prediction ability for one year MACE events(AUC:0.72),but combined with LVEF,age,the predictive ability of BNP was significantly increased(AUC:0.79).The sensitivity(73.2%)and specificity(80.0%)were also improved.Conclusion BNP is an effective predictor of MACE in ACS patients.The combination of LVEF,age and BNP can improve the predictive value of one year MACE in ACS patients.
作者 刘洪军 栾颖 刘承荣 LIU Hongjun;LUAN Ying;LIU Chengrong(Fengdu People's Hospital,Chongqing 408200,China)
出处 《大医生》 2020年第23期13-16,共4页 Doctor
基金 重庆市医学科研项目(编号:2015ZBXM093)。
关键词 急性冠脉综合征 B型利钠肽 左室射血分数 预后 acute coronary syndrome B-type natriuretic peptide left ventricular ejection fraction prognosis
  • 相关文献

参考文献6

二级参考文献69

  • 1王小艳.急性冠脉综合征后6个月死亡和心肌梗死的预测:前瞻性的多国观察性研究(GRACE)[J].中国处方药,2006(11):25-26. 被引量:138
  • 2柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2146
  • 3Antman EM,Cohen M,Bernink PJ,et al.The TIMI risk score for unstable angina/non-ST elevation MI:a method for prognostication and therapeutic decision making[J].JAMA,2000,284(7):835-842.
  • 4Boersma E,Pieper KS,Steyerberg EW,et al.Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation.Results from an international trial of 9 461 patients.The PURSUIT Investigators[J].Circulation,2000,101(6):2557-2567.
  • 5Granger CB,Goldberg RJ,Dabbous O,et al.Global Registry of Acute Coronary Events Investigators.Predictors of hospital mortality in the global registry of acute coronary events[J].Arch Intern Med,2003,163(19):2345-2353.
  • 6Squire IB,O′Brien RJ,Demme B,et al.N-terminal pro-atrial natriuretic peptide(NANP)and N-terminal pro-B-type natriuretic peptide(N-BNP)in the prediction of death and heart failure in unselected patients following acute myocardial infarction[J].Clin Sci,2004,107(3):309-316.
  • 7世界卫生组织、北京协和医院.ICD-10疾病和有关健康问题的国际统计分类[M].10版.北京:人民卫生出版社,2007:7.
  • 8Sudoh T,Kangawa K,Minamino N,et al.A new natriuretic peptide in porcine brain[J].Nature,1988,332(6195):78-81.
  • 9Dickstein K,Cohen-Solal A,Filippatos G,et al.ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008:the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology.Developed in collaboration with the Heart Failure Association of the ESC(HFA)and endorsed by the European Society of Intensive Care Medicine(ESICM)[J].Eur J Heart Fail,2008,10(10):1-55.
  • 10Nicholls MG,Frampton CM,Yandle TG,et al.BNP:not just for heart failure[J].Heart,2008,94(1):6-7.

共引文献89

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部